System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features (2016)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/211,462, filed Aug 28, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,201,666 | System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 10,926,043 | System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 12,564,688 | System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 11,865,323 | System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| Application 19/311,905 | System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features Pending Not granted | Bayer Healthcare LLC | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Bayer AG.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.